211 related articles for article (PubMed ID: 35571398)
1. Operable hepatitis B virus-related hepatocellular carcinoma: gut microbiota profile of patients at different ages.
Peng YC; Xu JX; Zeng CF; Zhao XH; You XM; Xu PP; Li LQ; Qi LN
Ann Transl Med; 2022 Apr; 10(8):477. PubMed ID: 35571398
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiome dysbiosis in patients with hepatitis B virus-related hepatocellular carcinoma after extended hepatectomy liver failure.
Peng YC; Xu JX; Zeng CF; Zhao XH; Li LQ; Qi LN
Ann Transl Med; 2022 May; 10(10):549. PubMed ID: 35722392
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota dysbiosis with hepatitis B virus liver disease and association with immune response.
Yan F; Zhang Q; Shi K; Zhang Y; Zhu B; Bi Y; Wang X
Front Cell Infect Microbiol; 2023; 13():1152987. PubMed ID: 37201112
[TBL] [Abstract][Full Text] [Related]
4. Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver disease.
Lin MJ; Su TH; Chen CC; Wu WK; Hsu SJ; Tseng TC; Liao SH; Hong CM; Yang HC; Liu CJ; Wu MS; Kao JH
Gut Pathog; 2023 May; 15(1):24. PubMed ID: 37218009
[TBL] [Abstract][Full Text] [Related]
5. Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma.
Huang H; Ren Z; Gao X; Hu X; Zhou Y; Jiang J; Lu H; Yin S; Ji J; Zhou L; Zheng S
Genome Med; 2020 Nov; 12(1):102. PubMed ID: 33225985
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota dysbiosis in patients with hepatitis B virus-induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma.
Zeng Y; Chen S; Fu Y; Wu W; Chen T; Chen J; Yang B; Ou Q
J Viral Hepat; 2020 Feb; 27(2):143-155. PubMed ID: 31600845
[TBL] [Abstract][Full Text] [Related]
7. The diagnostic potential of gut microbiome for early hepatitis B virus-related hepatocellular carcinoma.
Tang Y; Zhou H; Xiang Y; Cui F
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e167-e175. PubMed ID: 33208683
[TBL] [Abstract][Full Text] [Related]
8. Alteration in gut microbiota associated with hepatitis B and non-hepatitis virus related hepatocellular carcinoma.
Liu Q; Li F; Zhuang Y; Xu J; Wang J; Mao X; Zhang Y; Liu X
Gut Pathog; 2019; 11():1. PubMed ID: 30675188
[TBL] [Abstract][Full Text] [Related]
9.
Chen T; Ding R; Chen X; Lu Y; Shi J; Lü Y; Tang B; Zhang W; Ye C; Yuan M; Yang Z
Bioengineered; 2021 Dec; 12(1):8233-8246. PubMed ID: 34592890
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota as prognosis markers for patients with HBV-related acute-on-chronic liver failure.
Wang K; Zhang Z; Mo ZS; Yang XH; Lin BL; Peng L; Xu Y; Lei CY; Zhuang XD; Lu L; Yang RF; Chen T; Gao ZL
Gut Microbes; 2021; 13(1):1-15. PubMed ID: 34006193
[TBL] [Abstract][Full Text] [Related]
11. Integrated omics analysis: the relationship between significantly increased
Peng YC; Zhao XH; Zeng CF; Xu JX; Qi LN; Li LQ
J Gastrointest Oncol; 2022 Feb; 13(1):326-343. PubMed ID: 35284109
[TBL] [Abstract][Full Text] [Related]
12. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
Chen R; Wang J; Zhan R; Zhang L; Wang X
J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota dysbiosis in patients with hepatitis B virus-related cirrhosis.
Shu W; Shanjian C; Jinpiao L; Qishui O
Ann Hepatol; 2022; 27(2):100676. PubMed ID: 35093600
[TBL] [Abstract][Full Text] [Related]
14. Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma.
Zheng R; Wang G; Pang Z; Ran N; Gu Y; Guan X; Yuan Y; Zuo X; Pan H; Zheng J; Wang F
Cancer Med; 2020 Jun; 9(12):4232-4250. PubMed ID: 32281295
[TBL] [Abstract][Full Text] [Related]
15. [Association between obesity with the diversity and genus of gut microbiota in school-aged children].
Jiang LF; Wang YY; Peng H; Li R; Zhang F; Wang N; Shao QW; Jiang Q
Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Feb; 43(2):260-268. PubMed ID: 35184494
[No Abstract] [Full Text] [Related]
16. Characterization of Gut Microbiota and Exploration of Potential Predictive Model for Hepatocellular Carcinoma Microvascular Invasion.
Zhang N; Wang Z; Lv J; Zhang S; Liu Y; Liu T; Li W; Gong L; Zhang X; El-Omar EM; Lu W
Front Med (Lausanne); 2022; 9():836369. PubMed ID: 35372388
[TBL] [Abstract][Full Text] [Related]
17. Diversity of the fecal microbiota in Chinese ponies.
Lv S; Zhang Y; Zhang Z; Meng S; Pu Y; Liu X; Liu L; Ma Y; Liu W; Jiang L
Front Vet Sci; 2023; 10():1102186. PubMed ID: 36777669
[TBL] [Abstract][Full Text] [Related]
18. Alterations in the Gut Microbiota and Hepatitis-B-Virus Infection in Southern Chinese Patients With Coexisting Non-Alcoholic Fatty Liver Disease and Type-2 Diabetes Mellitus.
Han W; Huang C; Ji Y; Zhou L; Chen J; Hou J
Front Med (Lausanne); 2021; 8():805029. PubMed ID: 34993216
[No Abstract] [Full Text] [Related]
19. Saliva microbiome changes in thyroid cancer and thyroid nodules patients.
Jiao J; Zheng Y; Zhang Q; Xia D; Zhang L; Ma N
Front Cell Infect Microbiol; 2022; 12():989188. PubMed ID: 36034695
[TBL] [Abstract][Full Text] [Related]
20. Entecavir therapy reverses gut microbiota dysbiosis induced by hepatitis B virus infection in a mouse model.
Li X; Wu S; Du Y; Yang L; Li Y; Hong B
Int J Antimicrob Agents; 2020 Jul; 56(1):106000. PubMed ID: 32360229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
